Nanoco Group plc (NNOCF)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Nanoco Group plc (NNOCF) ist im Technology-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Bewertet mit 48/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 17. März 2026Nanoco Group plc (NNOCF) Technologieprofil & Wettbewerbsposition
Nanoco Group plc specializes in developing and manufacturing quantum dots for various applications, including displays, sensors, and medical imaging. With a global presence and a focus on advanced nanomaterials, Nanoco operates in the competitive semiconductor industry, licensing its technology to diverse markets.
Investmentthese
Nanoco Group plc presents a speculative investment opportunity within the nanomaterials sector. The company's focus on quantum dots for display and sensor applications offers potential for growth, driven by increasing demand for advanced display technologies and sensor solutions. With a market capitalization of $0.01 billion and negative P/E ratio of -4.83, the company's financial performance reflects its current stage of development. Key value drivers include successful licensing agreements and expansion into new markets. Ongoing catalysts include potential partnerships and advancements in quantum dot technology. Potential risks include competition from established players and the need for continued innovation to maintain a competitive edge.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $0.01 billion, reflecting its small-cap status.
- Negative P/E ratio of -4.83, indicating current losses.
- Gross margin of 73.9%, showcasing strong pricing power in its niche market.
- Profit margin of -28.8%, highlighting the need for improved operational efficiency.
- Beta of -0.01, suggesting low volatility compared to the market.
Wettbewerber & Vergleichsunternehmen
Staerken
- Proprietary quantum dot technology.
- Strong patent portfolio.
- Global presence and operations.
- Diverse applications across multiple industries.
Schwaechen
- Negative profitability.
- Small market capitalization.
- Reliance on licensing agreements.
- Limited brand recognition.
Katalysatoren
- Upcoming: Potential new licensing agreements for CFQD quantum dots in display applications.
- Ongoing: Expansion of HEATWAVE quantum dots in sensor technology market.
- Ongoing: Development of VIVODOTS nanoparticles for medical imaging.
- Ongoing: Strategic partnerships with leading technology companies to enhance market reach.
Risiken
- Potential: Competition from established nanomaterial companies.
- Potential: Technological obsolescence in the rapidly evolving semiconductor industry.
- Ongoing: Negative profitability and reliance on licensing agreements for revenue.
- Potential: Economic downturns affecting demand for display and sensor products.
Wachstumschancen
- Expansion in Display Technology: Nanoco can capitalize on the growing demand for quantum dot displays in TVs, monitors, and mobile devices. The quantum dot display market is projected to reach $34.1 billion by 2028. Nanoco's CFQD quantum dots offer superior color performance and energy efficiency, providing a competitive advantage. Timeline: Ongoing.
- Sensor Applications: The market for quantum dot-based sensors is expanding, driven by applications in environmental monitoring, industrial automation, and medical diagnostics. The global sensor market is expected to reach $278.7 billion by 2029. Nanoco's HEATWAVE quantum dots can be used to develop highly sensitive and accurate sensors. Timeline: Ongoing.
- Medical Imaging: Nanoco's VIVODOTS nanoparticles have potential applications in medical imaging and diagnostics. The medical imaging market is projected to reach $52.98 billion by 2029. These nanoparticles can be used to enhance the contrast and resolution of medical images, improving diagnostic accuracy. Timeline: Ongoing.
- Licensing Agreements: Nanoco can generate revenue through licensing its quantum dot technology to display manufacturers, sensor developers, and medical device companies. Licensing agreements provide a recurring revenue stream and allow Nanoco to expand its market reach without significant capital investment. Timeline: Ongoing.
- Strategic Partnerships: Collaborating with leading technology companies can accelerate the adoption of Nanoco's quantum dot technology. Strategic partnerships can provide access to new markets, distribution channels, and technical expertise. Forming alliances with key players in the display, sensor, and medical industries can enhance Nanoco's competitive position. Timeline: Ongoing.
Chancen
- Expansion in display technology market.
- Growth in sensor applications.
- Development of new medical imaging solutions.
- Strategic partnerships with leading technology companies.
Risiken
- Competition from established nanomaterial companies.
- Technological obsolescence.
- Economic downturns affecting demand for display and sensor products.
- Regulatory changes impacting the use of nanomaterials.
Wettbewerbsvorteile
- Proprietary technology in quantum dot development and manufacturing.
- Strong patent portfolio protecting its nanomaterial innovations.
- Established relationships with key players in the display and sensor industries.
Ueber NNOCF
Nanoco Group plc, founded in 2001 and based in Runcorn, UK, focuses on the research, development, manufacture, and licensing of novel nanomaterials. Originally named Evolutec Group plc, the company rebranded as Nanoco Group plc in 2009. Its core product is CFQD quantum dots, fluorescent semiconductor nanoparticles used in OLED and µLED color conversion, QD-EL, and security tagging. Additionally, Nanoco offers HEATWAVE quantum dots for sensor applications and VIVODOTS nanoparticles for medical and veterinary uses. The company operates globally, with a presence in the United Kingdom, Japan, Singapore, Holland, France, Taiwan, Canada, Saudi Arabia, and the United States. Nanoco licenses its technology and manufactures nanomaterials, positioning itself as a key player in the advanced materials sector.
Was das Unternehmen tut
- Researches and develops novel nanomaterials.
- Manufactures CFQD quantum dots for display applications.
- Produces HEATWAVE quantum dots for sensor technology.
- Creates VIVODOTS nanoparticles for medical and veterinary uses.
- Licenses its nanomaterial technology to various industries.
- Operates in the United Kingdom, Japan, Singapore, and other international markets.
Geschaeftsmodell
- Develops and manufactures quantum dots and other nanomaterials.
- Licenses its technology to companies in the display, sensor, and medical industries.
- Generates revenue through licensing fees and material sales.
Branchenkontext
Nanoco Group plc operates within the semiconductor industry, specifically focusing on nanomaterials and quantum dots. The industry is characterized by rapid technological advancements and intense competition. Market trends include the increasing demand for energy-efficient displays, advanced sensor technologies, and medical imaging solutions. Nanoco competes with companies developing similar nanomaterials and display technologies. The company's success depends on its ability to innovate and secure licensing agreements in this dynamic market.
Wichtige Kunden
- Display manufacturers seeking to improve color performance and energy efficiency.
- Sensor developers requiring highly sensitive and accurate sensing materials.
- Medical device companies looking to enhance medical imaging and diagnostics.
- Security companies using quantum dots for tagging and anti-counterfeiting measures.
Finanzdaten
Chart & Info
Nanoco Group plc (NNOCF) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer NNOCF verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer NNOCF.
Kursziele
Wall-Street-Kurszielanalyse fuer NNOCF.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von NNOCF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Liam Frederick Gray
CEO
Liam Frederick Gray serves as the CEO of Nanoco Group plc, managing a team of 47 employees. His background includes extensive experience in the technology sector, with a focus on nanomaterials and advanced materials. Gray has held various leadership positions in research and development, business development, and strategic planning. He is responsible for driving Nanoco's growth strategy, overseeing its operations, and managing its relationships with key stakeholders.
Erfolgsbilanz: Under Liam Frederick Gray's leadership, Nanoco Group plc has focused on expanding its licensing agreements and developing new applications for its quantum dot technology. Key milestones include securing partnerships with leading display manufacturers and expanding its presence in the sensor and medical imaging markets. Gray has also overseen the company's efforts to strengthen its patent portfolio and protect its intellectual property.
NNOCF OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that Nanoco Group plc may not meet the minimum financial or regulatory requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater risks due to less stringent listing standards compared to exchanges like NYSE or NASDAQ. Investors should exercise caution and conduct thorough due diligence before investing in OTC Other stocks.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for price volatility.
- Higher risk of fraud or manipulation.
- Less regulatory oversight compared to listed exchanges.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Check for any legal or regulatory issues.
- Review the company's investor relations materials.
- Consult with a financial advisor.
- Understand the risks associated with OTC investing.
- Established operations in multiple countries.
- Patent portfolio protecting its technology.
- Licensing agreements with reputable companies.
- Experienced management team.
- Presence in the nanomaterials sector.
Haeufige Fragen zu NNOCF
What are the key factors to evaluate for NNOCF?
Nanoco Group plc (NNOCF) currently holds an AI score of 48/100, indicating low score. Key strength: Proprietary quantum dot technology.. Primary risk to monitor: Potential: Competition from established nanomaterial companies.. This is not financial advice.
How frequently does NNOCF data refresh on this page?
NNOCF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven NNOCF's recent stock price performance?
Recent price movement in Nanoco Group plc (NNOCF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary quantum dot technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider NNOCF overvalued or undervalued right now?
Determining whether Nanoco Group plc (NNOCF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying NNOCF?
Before investing in Nanoco Group plc (NNOCF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding NNOCF to a portfolio?
Potential reasons to consider Nanoco Group plc (NNOCF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Proprietary quantum dot technology.. Additionally: Strong patent portfolio.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of NNOCF?
Yes, most major brokerages offer fractional shares of Nanoco Group plc (NNOCF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track NNOCF's earnings and financial reports?
Nanoco Group plc (NNOCF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for NNOCF earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data is based on the most recent available information.
- OTC market data may be limited or delayed.
- AI analysis is pending and may provide additional insights.